RARE
Ultragenyx Pharmaceutical Inc. · Healthcare
EVP and Chief Medical Officer Camille L Bedrosian sold $110K of Ultragenyx Pharmaceutical Inc.
Sold$109,859
$66.30Price
1,657Shares
−4%Stake
What RARE did after the filing
- The stock from Tue, Feb 1 open, $70.16
- −3.4%
- S&P 500, same days
- −3.3%
Measured over 30 trading days, to the Mar 16 close.
Traded Sun, Jan 30. Filed Tue, Feb 1, 8:39 AM ET, before the open. Returns use the Feb 1 open and the Mar 16 close. Not investment advice.